EBCOG Part 1-Maternal Medicine-Day 4(EMQ) EBCOG Part 1-Maternal Medicine-Day 4(EMQ) Name Email Phone Number A. Start IV prophylactic unfractionated heparin (UFH)B. Change to prophylactic IV UFHC. Change to heparinoid danaparoid sodiumD. Change to LMWHE. Start prophylactic LMWHF. Start dalteparinG. Monitor anti-Xa levelsH. Remove catheter 3 hrs after giving heparinI. Remove catheter 8 hrs after giving last dose of heparinJ. Remove catheter 12 hrs after giving last dose of heparinK. Remove catheter 24 hrs after giving last dose of heparinL. Withhold heparin for 12 hrs before giving spinal anaesthesiaM. Withhold heparin 24 hrs before giving SAN. Withhold heparin for 24 hrs before giving EAO. Withhold heparin for 48 hrs before giving EA. 1.43 year old,P3,presents to EPAU at 12 weeks of gestation with mild vaginal bleeding.She gives h/o unprovoked DVT 1 year prior to this pregnancy & was treated with warfarin for 6 mths.Currently the GP has started her on LDA in view of a previous h/o pre-eclampsia.Please select your answera. Start IV prophylactic unfractionated heparin (UFH)b. Change to prophylactic IV UFHc. Change to heparinoid danaparoid sodiumd. Change to LMWHe. Start prophylactic LMWHf. Start dalteparing. Monitor anti-Xa levelsh. Remove catheter 3 hrs after giving heparini. Remove catheter 8 hrs after giving last dose of heparinj. Remove catheter 12 hrs after giving last dose of heparink. Remove catheter 24 hrs after giving last dose of heparinl. Withhold heparin for 12 hrs before giving spinal anaesthesiam.Withhold heparin 24 hrs before giving SAn. Withhold heparin for 24 hrs before giving EAo. Withhold heparin for 48 hrs before giving EA.2. 40 year old P2,presents to obstetric day assessment unit at 28 weeks of gestation with reduced fetal movements.CTG is normal.Her notes say she had DVT at 20 weeks of gestation during her current pregnancy & she is on 80 mg LMWH twice daily.Her booking blood results were normal.However her recent blood test reveals a platelet count of 60 X 109/1.Please select your answera. Start IV prophylactic unfractionated heparin (UFH)b. Change to prophylactic IV UFHc. Change to heparinoid danaparoid sodiumd. Change to LMWHe. Start prophylactic LMWHf. Start dalteparing. Monitor anti-Xa levelsh. Remove catheter 3 hrs after giving heparini. Remove catheter 8 hrs after giving last dose of heparinj. Remove catheter 12 hrs after giving last dose of heparink. Remove catheter 24 hrs after giving last dose of heparinl. Withhold heparin for 12 hrs before giving spinal anaesthesiam.Withhold heparin 24 hrs before giving SAm.Withhold heparin 24 hrs before giving SAn. Withhold heparin for 24 hrs before giving EAo. Withhold heparin for 48 hrs before giving EA.3.P1,30 yrs old delivered 8 hrs ago.she gives h/o previous thrombophilia.she delivered by CS & had a massive PPH & her current Hb is 8 g/dl.The midwife informs you about minimal soakage of the CS wound dressing.Please select your answera. Start IV prophylactic unfractionated heparin (UFH)b. Change to prophylactic IV UFHc. Change to heparinoid danaparoid sodiumd. Change to LMWHe. Start prophylactic LMWHf. Start dalteparing. Monitor anti-Xa levelsh. Remove catheter 3 hrs after giving heparini. Remove catheter 8 hrs after giving last dose of heparinj. Remove catheter 12 hrs after giving last dose of heparinj. Remove catheter 12 hrs after giving last dose of heparink. Remove catheter 24 hrs after giving last dose of heparinl. Withhold heparin for 12 hrs before giving spinal anaesthesiam.Withhold heparin 24 hrs before giving SAn. Withhold heparin for 24 hrs before giving EAo. Withhold heparin for 48 hrs before giving EA.4. 33 year old P3,is seen by the SHO in the postnatal ward.She had a CS for failure to progress & is on epidural for pain relief for the past 4 hrs following the CS.The midwife has just given her the first dose of prophylactic LMWH postnatally.Please select your answera. Start IV prophylactic unfractionated heparin (UFH)b. Change to prophylactic IV UFHc. Change to heparinoid danaparoid sodiumd. Change to LMWHe. Start prophylactic LMWHf. Start dalteparing. Monitor anti-Xa levelsh. Remove catheter 3 hrs after giving heparini. Remove catheter 8 hrs after giving last dose of heparinj. Remove catheter 12 hrs after giving last dose of heparink. Remove catheter 24 hrs after giving last dose of heparinl. Withhold heparin for 12 hrs before giving spinal anaesthesiam.Withhold heparin 24 hrs before giving SAn. Withhold heparin for 24 hrs before giving EAo. Withhold heparin for 48 hrs before giving EA.5. A 38 year old,G3P2,is admitted for an elective CS for breech presentation.She had a pulmonary embolism during this pregnancy & has been on a therapeutic dose of LMWH for the past 3 mths.She took her last dose just before coming into the ward.Please select your answera. Start IV prophylactic unfractionated heparin (UFH)b. Change to prophylactic IV UFHc. Change to heparinoid danaparoid sodiumd. Change to LMWHe. Start prophylactic LMWHf. Start dalteparing. Monitor anti-Xa levelsh. Remove catheter 3 hrs after giving heparini. Remove catheter 8 hrs after giving last dose of heparinj. Remove catheter 12 hrs after giving last dose of heparink. Remove catheter 24 hrs after giving last dose of heparinl. Withhold heparin for 12 hrs before giving spinal anaesthesiam.Withhold heparin 24 hrs before giving SAn. Withhold heparin for 24 hrs before giving EAo. Withhold heparin for 48 hrs before giving EA.A.Acquired autoimmune disorder associated with vascular thrombotic events, pregnancy failure and clinical manifestations involving other organs, such as the heart, skin and central nervous systemB.During pregnancy, the risks are mostly cardiovascular (especially, that of aortic dissection)C.Most likely to occur during pregnancy or in the immediate postpartum period with differential diagnosis including PET/HELLP/ AFLP/TTP D.Fetal manifestations of passively acquired autoimmunityE.Approximately 80–90% of patients may be rheumatoid factor-positiveF.Risk of postpartum haemorrhage due to poor uterine tone and arterial fragilityG,Vasospasm compromising perfusion of peripheral areas of circulation, especially fingers and toes can result in severe pain due to ischaemiaH.Involvement in the form of oesophageal constriction is the most common clinical featureI.none of the above6.Neonatal lupus Please select your answerA.Acquired autoimmune disorder associated with vascular thrombotic events, pregnancy failure and clinical manifestations involving other organs, such as the heart, skin and central nervous systemB.During pregnancy, the risks are mostly cardiovascular (especially, that of aortic dissection) C.Most likely to occur during pregnancy or in the immediate postpartum period with differential diagnosis including PET/HELLP/ AFLP/TTPC.Most likely to occur during pregnancy or in the immediate postpartum period with differential diagnosis including PET/HELLP/ AFLP/TTPD.Fetal manifestations of passively acquired autoimmunityE.Approximately 80–90% of patients may be rheumatoid factor-positiveF.Risk of postpartum haemorrhage due to poor uterine tone and arterial fragilityG,Vasospasm compromising perfusion of peripheral areas of circulation, especially fingers and toes can result in severe pain due to ischaemiaH.Involvement in the form of oesophageal constriction is the most common clinical featureI.none of the above7.Lupus flarePlease select your answerA.Acquired autoimmune disorder associated with vascular thrombotic events, pregnancy failure and clinical manifestations involving other organs, such as the heart, skin and central nervous systemB.During pregnancy, the risks are mostly cardiovascular (especially, that of aortic dissection)C.Most likely to occur during pregnancy or in the immediate postpartum period with differential diagnosis including PET/HELLP/ AFLP/TTPD.Fetal manifestations of passively acquired autoimmunityE.Approximately 80–90% of patients may be rheumatoid factor-positiveF.Risk of postpartum haemorrhage due to poor uterine tone and arterial fragilityG,Vasospasm compromising perfusion of peripheral areas of circulation, especially fingers and toes can result in severe pain due to ischaemiaH.Involvement in the form of oesophageal constriction is the most common clinical featureI.none of the above8. Rheumatoid arthritisPlease select your answerA.Acquired autoimmune disorder associated with vascular thrombotic events, pregnancy failure and clinical manifestations involving other organs, such as the heart, skin and central nervous systemB.During pregnancy, the risks are mostly cardiovascular (especially, that of aortic dissection)C.Most likely to occur during pregnancy or in the immediate postpartum period with differential diagnosis including PET/HELLP/ AFLP/TTPD.Fetal manifestations of passively acquired autoimmunityE.Approximately 80–90% of patients may be rheumatoid factor-positiveF.Risk of postpartum haemorrhage due to poor uterine tone and arterial fragilityG,Vasospasm compromising perfusion of peripheral areas of circulation, especially fingers and toes can result in severe pain due to ischaemiaH.Involvement in the form of oesophageal constriction is the most common clinical featureI.none of the above9. SclerodermaPlease select your answerA.Acquired autoimmune disorder associated with vascular thrombotic events, pregnancy failure and clinical manifestations involving other organs, such as the heart, skin and central nervous systemB.During pregnancy, the risks are mostly cardiovascular (especially, that of aortic dissection)C.Most likely to occur during pregnancy or in the immediate postpartum period with differential diagnosis including PET/HELLP/ AFLP/TTPD.Fetal manifestations of passively acquired autoimmunityE.Approximately 80–90% of patients may be rheumatoid factor-positiveF.Risk of postpartum haemorrhage due to poor uterine tone and arterial fragilityG,Vasospasm compromising perfusion of peripheral areas of circulation, especially fingers and toes can result in severe pain due to ischaemiaH.Involvement in the form of oesophageal constriction is the most common clinical featureI.none of the above10.Ehlers-Danlos syndromePlease select your answerA.Acquired autoimmune disorder associated with vascular thrombotic events, pregnancy failure and clinical manifestations involving other organs, such as the heart, skin and central nervous systemB.During pregnancy, the risks are mostly cardiovascular (especially, that of aortic dissection)C.Most likely to occur during pregnancy or in the immediate postpartum period with differential diagnosis including PET/HELLP/ AFLP/TTPD.Fetal manifestations of passively acquired autoimmunityE.Approximately 80–90% of patients may be rheumatoid factor-positiveF.Risk of postpartum haemorrhage due to poor uterine tone and arterial fragilityG,Vasospasm compromising perfusion of peripheral areas of circulation, especially fingers and toes can result in severe pain due to ischaemiaH.Involvement in the form of oesophageal constriction is the most common clinical featureI.none of the above11.APLSPlease select your answerA.Acquired autoimmune disorder associated with vascular thrombotic events, pregnancy failure and clinical manifestations involving other organs, such as the heart, skin and central nervous systemB.During pregnancy, the risks are mostly cardiovascular (especially, that of aortic dissection)C.Most likely to occur during pregnancy or in the immediate postpartum period with differential diagnosis including PET/HELLP/ AFLP/TTPD.Fetal manifestations of passively acquired autoimmunityE.Approximately 80–90% of patients may be rheumatoid factor-positiveF.Risk of postpartum haemorrhage due to poor uterine tone and arterial fragilityG,Vasospasm compromising perfusion of peripheral areas of circulation, especially fingers and toes can result in severe pain due to ischaemiaH.Involvement in the form of oesophageal constriction is the most common clinical featureI.none of the above12.Marfan syndromePlease select your answerA.Acquired autoimmune disorder associated with vascular thrombotic events, pregnancy failure and clinical manifestations involving other organs, such as the heart, skin and central nervous systemB.During pregnancy, the risks are mostly cardiovascular (especially, that of aortic dissection)C.Most likely to occur during pregnancy or in the immediate postpartum period with differential diagnosis including PET/HELLP/ AFLP/TTPD.Fetal manifestations of passively acquired autoimmunityE.Approximately 80–90% of patients may be rheumatoid factor-positiveF.Risk of postpartum haemorrhage due to poor uterine tone and arterial fragilityG,Vasospasm compromising perfusion of peripheral areas of circulation, especially fingers and toes can result in severe pain due to ischaemiaH.Involvement in the form of oesophageal constriction is the most common clinical featureI.none of the above13.Raynaud’s phenomenonPlease select your answerA.Acquired autoimmune disorder associated with vascular thrombotic events, pregnancy failure and clinical manifestations involving other organs, such as the heart, skin and central nervous systemB.During pregnancy, the risks are mostly cardiovascular (especially, that of aortic dissection)C.Most likely to occur during pregnancy or in the immediate postpartum period with differential diagnosis including PET/HELLP/ AFLP/TTPD.Fetal manifestations of passively acquired autoimmunityE.Approximately 80–90% of patients may be rheumatoid factor-positiveF.Risk of postpartum haemorrhage due to poor uterine tone and arterial fragilityG,Vasospasm compromising perfusion of peripheral areas of circulation, especially fingers and toes can result in severe pain due to ischaemiaH.Involvement in the form of oesophageal constriction is the most common clinical featureI.none of the aboveTime is Up! By monisha|2021-03-25T11:36:40+00:00March 25, 2021|0 Comments Share This Story, Choose Your Platform! FacebookTwitterLinkedInRedditWhatsAppTumblrPinterestVkXingEmail About the Author: monisha Leave A Comment Cancel replyComment Save my name, email, and website in this browser for the next time I comment.
Leave A Comment